NCT05788861 Invasive Group A Streptococcal Infection
| NCT ID | NCT05788861 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | Sepsis Due to Streptococcus, Group A |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-09-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection
Eligibility Criteria
Inclusion Criteria: * Age\<18 years * Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis) Exclusion Criteria: * Opposition of the patient or his/her legal representative
Contact & Investigator
Yves Gillet
PRINCIPAL INVESTIGATOR
hôpital Femme-Mère-Enfant, Bron
Frequently Asked Questions
Who can join the NCT05788861 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 17 Years, studying Sepsis Due to Streptococcus, Group A. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05788861 currently recruiting?
Yes, NCT05788861 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT05788861 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT05788861 clinical trial?
NCT05788861 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Yves Gillet at hôpital Femme-Mère-Enfant, Bron. The trial plans to enroll 100 participants.